Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pablo Gil-Pérez"'
Autor:
Manuel Veas Porlán, Antonio Tello-Montoliu, Cecilia López-García, Pablo Gil-Pérez, Miriam Quintana-Giner, Raquel López-Gálvez, José Miguel Rivera-Caravaca, Francisco Marín, Domingo Pascual Figal
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 46, Iss , Pp 101195- (2023)
Background: Chronic renal failure (CKD) is associated with the presence of increased platelet reactivity and lower clinical benefit of clopidogrel. Ticagrelor has a more favorable pharmacodynamic and pharmacokinetic profile compared to clopidogrel, w
Externí odkaz:
https://doaj.org/article/9fae03c9328d46bb8bcb4a9aebd91be6
Autor:
José Miguel Rivera-Caravaca, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Pablo Gil-Pérez, Cecilia López-García, María Asunción Esteve-Pastor, Esteban Orenes-Piñero, Antonio Tello-Montoliu, Francisco Marín
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 7113 (2021)
Peripheral artery disease (PAD) is a major cause of morbidity and mortality but it is usually underdiagnosed and undertreated. Patients with PAD present dysregulated procoagulant, anticoagulant, and fibrinolytic pathways leading to arterial and venou
Externí odkaz:
https://doaj.org/article/ec3656ab16df40ef9a09a4c6cbbecfbd
Autor:
María Asunción Esteve-Pastor, Antonio Tello-Montoliu, Francisco Marín, Pablo Gil-Pérez, Esteban Orenes-Piñero, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Cecilia López-García, José Miguel Rivera-Caravaca
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7113, p 7113 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Peripheral artery disease (PAD) is a major cause of morbidity and mortality but it is usually underdiagnosed and undertreated. Patients with PAD present dysregulated procoagulant, anticoagulant, and fibrinolytic pathways leading to arterial and venou
Autor:
Pablo Gil-Pérez, Francisco Marín, Cecilia López-García, Eva Quero, Miriam Quintana-Giner, Ana I. Romero-Aniorte, Luis Muñoz, María Asunción Esteve-Pastor, A Veliz-Martinez, José Miguel Rivera-Caravaca, Vanessa Roldán, Gregory Y.H. Lip, Concepción Fernandez-Redondo
Publikováno v:
Rivera-Caravaca, J M, Gil-Perez, P, Lopez-García, C, Veliz-Martínez, A, Quintana-Giner, M, Romero-Aniorte, A I, Fernandez-Redondo, C, Muñoz, L, Quero, E, Esteve-Pastor, M A, Lip, G Y H, Roldán, V & Marín, F 2020, ' A nurse-led atrial fibrillation clinic : Impact on anticoagulation therapy and clinical outcomes ', International Journal of Clinical Practice, vol. 74, no. 12, e13634 . https://doi.org/10.1111/ijcp.13634
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
BACKGROUND: Nurses play a central role in the management of atrial fibrillation (AF) patients. An unresolved question is whether a nurse-led clinic would improve clinical outcomes. Herein, we investigated the impact of a nurse-led clinic on anticoagu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9598e1696d1521cc9c7d1d5f6cea6113
https://vbn.aau.dk/da/publications/629f14f5-1188-4d53-be30-26f9870078aa
https://vbn.aau.dk/da/publications/629f14f5-1188-4d53-be30-26f9870078aa
Autor:
Ricardo Humarán Fernández, Lilian García Rey, Alina Véliz Barroso, Marta Díaz Valdés, Pablo Gil Pérez
Publikováno v:
Revista Cubana de Medicina General Integral, Vol 13, Iss 3, Pp 207-211 (1997)
Planteamos el posible reconocimiento del síndrome neuroléptico maligno mediante un nuevo concepto de síndrome extrapiramidal maligno, que se ajustaría más a la sintomatología y a la respuesta fisiológica de la vía extrapiramidal. Se da import
Externí odkaz:
https://doaj.org/article/837cf4f6f14846a498740887a6633f4b
Autor:
Pablo Gil-Pérez, Carlos Rodríguez-Rojas, Cecilia López-García, Juan Antonio Vílchez, José Miguel Rivera-Caravaca, Francisco Marín, A Veliz-Martinez, Vanessa Roldán, María Dolores Albadalejo-Otón
Publikováno v:
Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 68(8)
Growth differentiation factor 15 (GDF-15) has been suggested as a prognostic biomarker for bleeding and mortality in atrial fibrillation (AF). To date, serum and EDTA matrices are standardized for the GDF-15 assay but it is unclear if it can be measu